Website in archive mode. Questions? Email [email protected]

  Eli Lilly and Co ( LLY ) |
1994 - 2021 (28 years)

Net Revenue (Sales) is 
$27.0B (1Y +10.9% )

LLY Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for LLY competitors.
AMGN GSK NVS BMY JNJ PFE SNY MRK ABBV
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $14.2B +1.8x
( +3.7% / year avg)
chevron_left 1994 $5.1B
vertical_align_top Peak $24.4B +3.76x
vertical_align_bottom Bottom $5.1B
arrow_drop_up # Up Years 19 19 of 28
years up.
arrow_drop_down # Down Years 9
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • LLY's stock price has rallied +58,827% from $0.25 in 1994 , or +326x faster than it's net revenue (sales) over the same period.
  • If LLY grows it's stock at the same rate as it's net revenue (sales) (+3.7%/year) , it's stock price will grow +143% and hit $215.67 over the next 10 years.
  • LLY's stock price has gone up 12 of the 19 years (+63%) it's net revenue (sales) were also up.
5-Year Change 🚀
+39.9%$27.2BNet Revenue (Sales)
+42.0%$7.5BCost of Revenue (Sales)
+39.1%$19.7BGross Profit Margin
+38.0%$6.7BResearch and Development (R&D)
+444%$1.6BOther Income/Expenses, Net
+21.0%$13.0BTotal Operating Expenses
+27.9%$20.6BCost & Expenses
-9.21%$1.4BDepreciation & Amortization (D&A)
+63.6%$8.1BEBITDA
+96.7%$6.7BOperating Income
-58.8%-$430.0MTotal Other Income/Expenses
+160%$5.9BPretax Income (Earnings)
+86.2%0.87Pretax Income (Earnings) Margin
-4.42%$484.4MProvision For Income Taxes
+207%$5.4BNet Income (Earnings)
+254%5.65Earnings Per Share (EPS)
+254%5.65Earnings Per Share (EPS) Diluted
-13.1%$3.8BShares Outstanding
-13.1%$3.8BShares Outstanding (Diluted)
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996 FY 1995
    1 Revenue 24539800000 22319500000 24555700000 22871300000 21222100000 19958700000 19615600000 23113100000 22603400000 24286500000 23076000000 21836000000 20378000000 18633500000 15691000000 14645300000 13857900000 12582500000 11077500000 11542500000 10862200000 10002900000 9236800000 8517600000 7346600000 6763800000
    2 Cost of Revenue 5483300000 4721200000 6430000000 6070200000 5654900000 5037200000 4932500000 4908100000 4796500000 5067900000 4366200000 4247000000 4382800000 4248800000 3546500000 3474200000 3223900000 2675100000 2176500000 2160200000 2055700000 1658300000 1524700000 1853100000 1574900000 1332000000
    3 Gross Profit (Income) 19056500000 17598300000 18125700000 16801100000 15567200000 14921500000 14683100000 18205000000 17806900000 19218600000 18709800000 17589000000 15995200000 14384700000 12144500000 11171100000 10634000000 9907400000 8901000000 9382300000 8806500000 8344600000 7712100000 6664500000 5771700000 5431800000
    4 R&D 6085700000 5595000000 5307100000 5281800000 5243900000 4796400000 4733600000 5531300000 5278100000 5020800000 4884200000 4326500000 3840900000 3486700000 3129300000 3025500000 2691100000 2350200000 2149300000 2235100000 2018500000 1783600000 1738900000 1382000000 1189500000 1042300000
    5 SG&A 6121200000.00 0.00 0.00 513700000.00 0.00 0.00 0.00 0.00 0.00 7879900000.00 7053400000.00 6892500000.00 6626400000.00 6095100000.00 4889800000.00 4497000000.00 4284200000.00 4055400000.00 3424000000.00 3417400000.00 3228300000.00 2757600000.00 2658300000.00 2314400000.00 1991900000.00 1854000000.00
    6 Other Expenses 1498500000.00 554500000.00 185600000.00 110100000.00 195600000.00 341500000.00 368300000.00 559300000.00 746800000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Operating Expenses 12206900000 11808800000 11938900000 12383600000 11695900000 11329400000 11354400000 12656900000 12791600000 12900700000 11937600000 11219000000 10467300000 9581800000 8019100000 7522500000 6975300000 6405600000 5573300000 5652500000 5246800000 4980900000 4887600000 4206200000 3724900000 3450000000
    8 Interest Expense 359600000.00 400600000.00 272100000.00 225000000.00 185200000.00 161200000.00 148800000.00 160100000.00 177800000.00 186000000.00 185500000.00 261300000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 D&A 1323900000 1232600000 1609000000 1567300000 1496600000 1427700000 1379000000 1445600000 1462200000 1373600000 1328200000 1297800000 1122600000 1047900000 801800000 726400000 597500000 548500000 493000000 454900000 435800000 439700000 490400000 509800000 543500000 553700000
    10 EBITDA 8173500000 7022100000 7795800000 5984800000 5367900000 5019800000 4707700000 6993700000 6477500000 7691500000 8100400000 7667800000 6650500000 5850800000 4927200000 4375000000 4256200000 4050300000 3820700000 4184700000 3995500000 3803400000 3314900000 2968100000 2590300000 2535500000
    11 Operating Income 6849600000 5789500000 6186800000 4417500000 3871300000 3592100000 3328700000 5548100000 5015300000 6317900000 6772200000 6370000000 5527900000 4802900000 4125400000 3648600000 3658700000 3501800000 3327700000 3729800000 3559700000 3363700000 2824500000 2458300000 2046800000 1981800000
    12 Other Income Expenses (Net) 706900000 -203400000 -2280300000 -2162400000 -420800000 -727900000 -300600000 381600000 465700000 -862300000 -113400000 -826100000 -6817900000 -913100000 -731200000 -825900000 -665200000 -179100000 209700000 -31200000 481300000 65500000 21800000 -1714000000 273300000 70100000
    13 Pre-Income Tax 7229900000 5265900000 3795700000 2197400000 3374000000 2790000000 3000300000 5889300000 5408200000 5349500000 6525200000 5357800000 -1307600000 3876800000 3418000000 2717500000 2941900000 3261700000 3457700000 3552100000 3858700000 3245400000 2665000000 510200000 2031300000 1765600000
    14 Income Tax Expense 1036200000 628000000 563700000 2401500000 636400000 381600000 609800000 1204500000 1319600000 1001800000 1455700000 1029000000 764300000 923800000 755300000 715900000 1131800000 700900000 749800000 742700000 800900000 698700000 568700000 895300000 507800000 459000000
    15 Net Income 6193700000 8318400000 3232000000 -204100000 2737600000 2408400000 2390500000 4684800000 4088600000 4347700000 5069500000 4328800000 -2071900000 2953000000 2662700000 1979600000 1810100000 2560800000 2707900000 2780000000 3057800000 2721000000 2097900000 -385100000 1523500000 2290900000
    16 EPS 6.82 8.69 3.14 -0.19 2.49 2.18 2.15 4.19 3.57 3.90 4.58 3.94 -1.89 2.71 2.45 1.82 1.67 2.38 2.51 2.58 2.83 2.50 1.91 -0.35 1.39 2.01
    17 EPS Diluted 6.79 8.69 3.13 -0.19 2.49 2.18 2.15 4.19 3.57 3.90 4.58 3.94 -1.89 2.71 2.45 1.81 1.66 2.37 2.50 2.55 2.79 2.46 1.87 -0.35 1.36 1.95
    18 Shares Outstanding 956581598 957526000 1027721000 1052023000 1100875000 1105267000 1110627000 1116795000 1146493000 1113923000 1105788000 1098338000 1094499000 1089667897 1086816327 1087692308 1083892216 1075966387 1078844622 1077519380 1080494700 1088360000 1097486911 1107714286 1093453237 1136923077
    19 Shares Outstanding (Diluted) 956581598 957526000 1033667000 1052023000 1100875000 1105267000 1110627000 1116795000 1146493000 1113967000 1105813000 1098367000 1094499000 1089667897 1086816327 1093701657 1090421687 1080506329 1083160000 1090196078 1095985663 1106056911 1120962567 1107714286 1123426000 1176944000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996 FY 1995
    1 Cash & Cash Equivalents 3657100000 2337500000 7998200000 6536200000 4582100000 3666400000 3871600000 3830200000 4018800000 5922500000 5993200000 4462900000 5496700000 3220500000 3109300000 3006700000 5365300000 2756300000 1945900000 2702300000 4114900000 3700400000 1495700000 1947500000 813700000 999500000
    2 Short Term Investments 24200000.00 101000000.00 88200000.00 1497900000.00 1456500000.00 785400000.00 955400000.00 1567100000.00 1665500000.00 974600000.00 733800000.00 34700000.00 429400000.00 1610700000.00 781700000.00 2031000000.00 2099100000.00 957000000.00 1708800000.00 1028700000.00 503300000.00 135600000.00 0.00 0.00 0.00 0.00
    3 Cash & S-T Investments 3681300000 2438500000 8086400000 8034100000 6038600000 4451800000 4827000000 5397300000 5684300000 6897100000 6727000000 4497600000 5926100000 4831200000 3891000000 5037700000 7464400000 3713300000 3654700000 3731000000 4618200000 3836000000 1495700000 1947500000 813700000 999500000
    4 Accounts Receivables 6929000000 5541500000 6204900000 5262200000 4766300000 4071600000 3801300000 4022800000 3888300000 4237900000 4158100000 3831800000 3277300000 3704800000 2694400000 2761700000 2553000000 2332300000 2074200000 1695200000 1966100000 1842800000 2243700000 1883200000 1737100000 1808400000
    5 Inventory 3980300000 3190700000 4111800000 4458300000 3561900000 3445800000 2740000000 2928800000 2643800000 2299800000 2517700000 2849900000 2493200000 2523700000 2270300000 1878000000 2291600000 1963000000 1495400000 1060200000 883100000 899600000 999900000 900700000 881400000 839600000
    6 Other Current Assets 3926000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 475600000.00 477100000.00 667500000.00 589300000.00 459100000.00 491100000.00
    7 Total Current Assets 17462100000 13709600000 20549600000 19202100000 15101400000 12573600000 12179800000 13104700000 13038700000 14248200000 14840000000 12486500000 12453300000 12256900000 9694400000 10795800000 12835800000 8758700000 7804100000 6938900000 7943000000 7055500000 5406800000 5320700000 3891300000 4138600000
    8 PP&E 8681900000 8405000000 8919500000 8826500000 8252600000 8053500000 7963900000 7975500000 7760200000 7760300000 7940700000 8197400000 8626300000 8575100000 8152300000 7912500000 7550900000 6539000000 5293000000 4532400000 4176600000 3981500000 4096300000 4101700000 4307000000 4239300000
    9 Goodwill 3766500000.00 3679400000.00 4347500000.00 4370100000.00 3972700000.00 4039900000.00 1758100000.00 1516800000.00 1501300000.00 1434700000.00 1423900000.00 1175000000.00 1167500000.00 745700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    10 Intangible Assets 7450000000.00 6618000000.00 3521000000.00 4029200000.00 4357900000.00 5034800000.00 2884200000.00 2814300000.00 3251400000.00 3693400000.00 3394900000.00 2524800000.00 2886600000.00 1709700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 118600000.00 1517900000.00 1550500000.00 4028200000.00 4105200000.00
    11 Goodwill & Intangible Assets 11216500000.00 10297400000.00 7868500000.00 8399300000.00 8330600000.00 9074700000.00 4642300000.00 4331100000.00 4752700000.00 5128100000.00 4818800000.00 3699800000.00 4054100000.00 2455400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 118600000.00 1517900000.00 1550500000.00 4028200000.00 4105200000.00
    12 L-T Investments 2967000000.00 1962000000.00 2005000000.00 5679000000.00 5208000000.00 3647000000.00 4569000000.00 7625000000.00 6314000000.00 4030000000.00 1780000000.00 1156000000.00 1545000000.00 577000000.00 1002000000.00 1297000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    13 Tax Assets 2830400000.00 2572600000.00 2657700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Other Non-Current Assets 3475400000 2339100000 1892400000 2874300000 1913800000 2220500000 7823300000 2212500000 2534000000 2493400000 1622400000 1921400000 4078900000 3500400000 4108700000 5872500000 4480300000 6380400000 5944900000 4962800000 2571200000 1669600000 1574500000 1604500000 2080700000 1929400000
    15 Total Non-Current Assets 29171000000 25576500000 23358800000 25778900000 23704500000 22995300000 24998400000 22144000000 21360200000 19411600000 16161400000 14974400000 16759300000 14530900000 12261000000 13785000000 12031200000 12919400000 11237900000 9495200000 6747800000 5769700000 7188700000 7256700000 10415900000 10273900000
    16 Other Assets 9274000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 46633100000 39286100000 43908400000 44981000000 38805900000 35568900000 37178200000 35248700000 34398900000 33659800000 31001400000 27460900000 29212600000 26787800000 21955400000 24580800000 24867000000 21678100000 19042000000 16434100000 14690800000 12825200000 12595500000 12577400000 14307200000 14412500000
    18 Accounts Payables 1606700000 1405300000 1412300000 1410700000 1349300000 1338200000 1128100000 1119300000 1188300000 1125200000 1072200000 968100000 885800000 1018500000 789400000 781300000 648600000 875900000 676900000 624100000 661900000 445500000 1186000000 985500000 829300000 1018000000
    19 S-T Debt 8700000.00 1499300000.00 1131200000.00 3706600000.00 1937400000.00 6100000.00 2688700000.00 1012600000.00 11900000.00 1522300000.00 156000000.00 27400000.00 5846300000.00 413700000.00 219400000.00 734700000.00 2020600000.00 196500000.00 545400000.00 286300000.00 184300000.00 241500000.00 181400000.00 227600000.00 1212900000.00 1908800000.00
    20 Income Tax Payables 495000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Current Liabilities 2750300000 2189400000 2213400000 2832100000 2220900000 2460300000 2472600000 2328400000 2738900000 2903500000 4023900000 3793700000 6377600000 3836100000 4076700000 4200300000 4924500000 4478200000 3841200000 4292600000 4114500000 3248400000 3239800000 2978500000 2180000000 2040200000
    23 Total Current Liabilities 12481600000 11775200000 11888100000 14535900000 10986600000 8229600000 11207500000 8916600000 8389500000 8930900000 7101400000 6568100000 13109700000 5268300000 5085500000 5716300000 7593700000 5550600000 5063500000 5203000000 4960700000 3935400000 4607200000 4191600000 4222200000 4967000000
    24 L-T Debt 16586600000 13817900000 11639700000 9940500000 8367800000 7972400000 5367700000 4200300000 5519400000 5464700000 6770500000 6634700000 4615700000 4593500000 3494400000 5763500000 4491900000 4687800000 4358200000 3132100000 2633700000 2811900000 2185500000 2326100000 2516500000 2592900000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996 FY 1995
    1 Net Income (Earnings) 6193700000 8318400000 3232000000 -204100000 2737600000 2408400000 2390500000 4684800000 4088600000 4347700000 5069500000 4328800000 -2071900000 2953000000 2662700000 1979600000 1810100000 2560800000 2707900000 2780000000 3057800000 2721000000 2097900000 -385100000 1523500000 2290900000
    2 D&A 1323900000 1232600000 1609000000 1567300000 1496600000 1427700000 1379000000 1445600000 1462200000 1373600000 1328200000 1297800000 1122600000 1047900000 801800000 726400000 597500000 548500000 493000000 454900000 435800000 439700000 490400000 509800000 543500000 553700000
    3 Deferred Income Tax -134500000 62400000 326800000 -787900000 439500000 -748400000 -36400000 285900000 126000000 -268500000 559700000 189900000 442600000 122900000 346800000 -347500000 772400000 130900000 346500000 273800000 -442700000 27100000 25400000 -293000000 207300000 144000000
    4 Stock-Based Compensation (SBC) 308100000.00 312400000.00 279500000.00 281300000.00 255300000.00 217800000.00 156000000.00 144900000.00 141500000.00 147400000.00 231000000.00 368500000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 Change in Working Capital 3046100000 -6727100000 3995300000 551400000 -229200000 3371700000 -3215800000 -461100000 -668100000 -2421300000 1820200000 6574800000 -7645000000 2379700000 -470600000 -162600000 2034000000 467500000 1004700000 -1246400000 -137800000 2320500000 -329500000 1460000000 497500000 878800000
    6 Accounts Receivables -1350000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Inventory -533400000.00 -258700000.00 7800000.00 -253900000.00 -328200000.00 -736300000.00 -307100000.00 -286500000.00 -307900000.00 203100000.00 157000000.00 -179000000.00 84800000.00 154300000.00 -60200000.00 72100000.00 -111600000.00 -170800000.00 -285100000.00 -184200000.00 9800000.00 16900000.00 -55600000.00 -65800000.00 -42200000.00 -22100000.00
    8 Accounts Payables 1271300000.00 -477700000.00 -284500000.00 916300000.00 819000000.00 461600000.00 -260700000.00 -70300000.00 -336100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 Other Working Capital 4980500000 1934400000 8661500000 4666200000 4114800000 4344000000 972300000 4188100000 4649200000 5317300000 7738600000 5918400000 -656400000 6988600000 4608900000 5079500000 5242100000 3208100000 2740600000 1735900000 2982300000 3120100000 799600000 1129100000 -330900000 -828400000
    10 Other Non-Cash Items 994300000.00 588300000.00 2455900000.00 1554100000.00 409500000.00 571400000.00 371300000.00 62200000.00 -667300000.00 4582100000.00 -66300000.00 421000000.00 5048000000.00 463500000.00 1156700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -93000000.00 -37800000.00 -97800000.00 -9800000.00
    11 Net Cash Provided by Operating Activities 6499600000 4836600000 5524500000 5615600000 4851000000 2772800000 4367100000 5735000000 5304800000 7234500000 6856800000 4335500000 7295600000 5154500000 3975900000 1913600000 2869500000 3646700000 2070700000 3661600000 3731500000 2619700000 2629800000 2400400000 1991400000 1824600000
    12 Investments in PP&E -1387900000 -1033900000 -1210600000 -1076800000 -1037000000 -1066200000 -1162600000 -1012100000 -905400000 -672000000 -694300000 -765000000 -947200000 -1082400000 -1077800000 -1298100000 -1898100000 -1706600000 -1130900000 -884000000 -677900000 -528300000 -419900000 -366300000 -443900000 -551300000
    13 Acquisitions (Net) -849000000.00 -6563000000.00 0.00 -882000000.00 -45000000.00 -5283000000.00 -551000000.00 -44000000.00 -199000000.00 -308000000.00 -609000000.00 0.00 -6083000000.00 -2673000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Purchase of Investments -370100000.00 -290200000.00 -950100000.00 -8001300000.00 -5673400000.00 -4068700000.00 -11440500000.00 -15572900000.00 -7618600000.00 -4710300000.00 -1753700000.00 -432300000.00 -2412400000.00 -1127600000.00 -1313200000.00 -1183100000.00 -13086700000.00 -7005300000.00 -5842100000.00 -3061700000.00 0.00 -162800000.00 -57600000.00 -388500000.00 -294300000.00 -372900000.00
    15 Sales/Maturities of Investments 886800000 746400000 6062000000 7438500000 3728000000 5230200000 15063500000 14555100000 4730800000 2138500000 584700000 1506900000 2554900000 800100000 2755200000 607800000 14849300000 7536400000 4777900000 319000000 983900000 216100000 273100000 365700000 396900000 430800000
    16 Other Investing Activities 102800000 -248700000 -191300000 -215800000 -130100000 5272000000 -5430100000 -97400000 1276500000 -277200000 -219300000 -94500000 -406800000 -277300000 179000000 -353600000 -498100000 -217200000 -316100000 -369700000 -1362500000 -116600000 -120100000 -34200000 -40800000 -54100000
    17 Net Cash used for Investing Activities -2258900000 -8082900000 1906000000 -3783600000 -3139100000 26800000 -3909100000 -2072800000 -2832800000 -4824400000 -3159800000 142800000 -7268800000 -4328100000 608400000 -2215900000 -684800000 -1331500000 -2474400000 -3964800000 -1056500000 1086700000 -293900000 809700000 -468000000 -562800000
    18 Debt Repayment -276500000.00 -2866400000.00 -1009100000.00 -630600000.00 -200000.00 -1955700000.00 -1034800000.00 -10500000.00 -1500600000.00 -54600000.00 -1100000.00 -5824200000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    19 Common Stock Issued 0.00 0.00 1659700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 24700000.00 59600000.00 105900000.00 104500000.00 103100000.00 64600000.00 109500000.00 178400000.00 310200000.00 414000000.00 365400000.00 218400000.00 54700000.00
    20 Common Stock Repurchased -500000000.00 -4400000000.00 -4150700000.00 -299800000.00 -600100000.00 -749500000.00 -800000000.00 -1698100000.00 -721100000.00 0.00 0.00 0.00 0.00 0.00 -122100000.00 -377900000.00 0.00 -281100000.00 -385200000.00 -545700000.00 -1052800000.00 -1453000000.00 -2172600000.00 -351300000.00 -314500000.00 -156000000.00
    21 Dividends Paid -2687100000 -2409800000 -2311800000 -2192100000 -2158500000 -2127300000 -2101200000 -2120700000 -2187400000 -2180100000 -2165300000 -2152100000 -2056700000 -1853600000 -1736300000 -1654900000 -1539800000 -1443000000 -1335800000 -1207200000 -1126000000 -1000500000 -877700000 -818000000 -753200000 -747200000
    22 Other Financing Activities -241600000.00 -200100000.00 -372800000.00 -364400000.00 -300800000.00 139200000.00 187400000.00 0.00 0.00 6000000.00 19400000.00 42600000.00 -8100000.00 -600000.00 9900000.00 39800000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    23 Net Cash Used Provided by Financing Activities -3137100000 -2324500000 -5904900000 142600000 -559800000 -2919200000 -75100000 -3829300000 -4419600000 -2369900000 -2021900000 -5533700000 2346000000 -844900000 -4578800000 -1880500000 203700000 -1578300000 -422000000 -1048700000 -2229500000 -1452700000 -2812700000 -1954600000 -1661100000 -813700000
    24 Net Change in Cash 1319600000.00 -5660700000.00 1462000000.00 1954100000.00 915700000.00 -205200000.00 41400000.00 -188600000.00 -1903700000.00 -70700000.00 1530300000.00 -1033800000.00 2276200000.00 111200000.00 102600000.00 -2358600000.00 2609000000.00 810400000.00 -756400000.00 -1412600000.00 414500000.00 2204700000.00 -451800000.00 1133800000.00 -185800000.00 462600000.00
  • About
    Industry: Drug Manufacturers General
    Sector: Healthcare
    Country: US
    IPO Date: 7/9/1970
    Stonk Exchange: NYSE
    • Eli Lilly & Co
    • engages in the discovery, development, manufacture and sale of pharmaceutical products.
    • The company is headquartered in Indianapolis, Indiana and currently employs 38,680 full-time employees.
    • The firm discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products.
    • The firm's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.
    • Its animal health business segment develops, manufactures and markets products for both food animals and companion animals.
    • The firm's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products.
    • The firm's animal health products segment includes products for food animals and products for companion animals.
    • As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.



Looking for a specific stock? Please use our search ("TSLA, AAPL, SPY...") at the top. Otherwise, you can refer to the lists below.
List of all stocks by first letter/number.